Financial Ratios Top Glove Corporation Bhd.
Stocks
TOPGLOV
MYL7113OO003
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8050 MYR | -3.01% |
|
-0.62% | +24.81% |
| 03:54am | Malaysian Government Pension Fund Hikes Stake in Top Glove | MT |
| 06-09 | AEM, Top Glove and PC Partner Among New Entrants in iEdge Singapore Next 50 Index Update | MT |
| Fiscal Period: August | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 66.87 | 1.77 | -4.43 | -1.7 | 0.15 | |||||
Return on Total Capital | 85.59 | 2.13 | -4.9 | -1.87 | 0.17 | |||||
Return On Equity % | 116.68 | 4.02 | -13.92 | -0.36 | 2.32 | |||||
Return on Common Equity | 115.65 | 3.24 | -14.63 | -1.11 | 2 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 67.86 | 17.11 | 2.85 | 10.55 | 14.22 | |||||
SG&A Margin | 7.41 | 12.56 | 26.68 | 18.13 | 13.77 | |||||
EBITDA Margin % | 62.29 | 10.63 | -8.93 | 3.62 | 9.05 | |||||
EBITA Margin % | 60.47 | 4.62 | -23.67 | -7.43 | 0.56 | |||||
EBIT Margin % | 60.45 | 4.55 | -23.83 | -7.58 | 0.45 | |||||
Income From Continuing Operations Margin % | 47.82 | 5.05 | -39.23 | -0.85 | 3.52 | |||||
Net Income Margin % | 47.44 | 4.95 | -38.92 | -0.73 | 3.68 | |||||
Net Avail. For Common Margin % | 47.12 | 4.05 | -40.99 | -2.58 | 3.02 | |||||
Normalized Net Income Margin | 37.92 | 3.83 | -13.88 | -3.56 | 1.63 | |||||
Levered Free Cash Flow Margin | 29.5 | -16.6 | -11.03 | 3.89 | 1.63 | |||||
Unlevered Free Cash Flow Margin | 29.51 | -16.55 | -10.68 | 4.13 | 2.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.77 | 0.62 | 0.3 | 0.36 | 0.53 | |||||
Fixed Assets Turnover | 4.43 | 1.25 | 0.51 | 0.64 | 0.96 | |||||
Receivables Turnover (Average Receivables) | 24.93 | 14.43 | 11.34 | 9.9 | 9.14 | |||||
Inventory Turnover (Average Inventory) | 6.22 | 5.33 | 4.97 | 6.62 | 8.28 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.98 | 2.12 | 1.83 | 1.93 | 2.7 | |||||
Quick Ratio | 1.41 | 1.46 | 1.26 | 1.46 | 1.95 | |||||
Operating Cash Flow to Current Liabilities | 3.56 | 0.18 | 0.13 | 0.02 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 14.64 | 25.3 | 32.19 | 36.99 | 39.94 | |||||
Days Outstanding Inventory (Average Inventory) | 58.66 | 68.44 | 73.4 | 55.3 | 44.08 | |||||
Average Days Payable Outstanding | 18.19 | 18.42 | 24.42 | 21.31 | 24.05 | |||||
Cash Conversion Cycle (Average Days) | 55.11 | 75.32 | 81.17 | 70.98 | 59.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.68 | 6.14 | 9.82 | 7.23 | 17.79 | |||||
Total Debt / Total Capital | 6.26 | 5.78 | 8.94 | 6.75 | 15.1 | |||||
LT Debt/Equity | 2.27 | 1.59 | 0.67 | 0.38 | 17.13 | |||||
Long-Term Debt / Total Capital | 2.13 | 1.5 | 0.61 | 0.35 | 14.54 | |||||
Total Liabilities / Total Assets | 26.19 | 16.31 | 16.08 | 16.13 | 23.89 | |||||
EBIT / Interest Expense | 2.36K | 57.39 | -42.21 | -19.17 | 0.71 | |||||
EBITDA / Interest Expense | 2.44K | 136.14 | -15.3 | 9.75 | 14.5 | |||||
(EBITDA - Capex) / Interest Expense | 2.12K | -78.74 | -43.91 | -4.61 | 8.26 | |||||
Total Debt / EBITDA | 0.05 | 0.69 | -2.98 | 4.35 | 2.64 | |||||
Net Debt / EBITDA | -0.2 | -0.89 | 1.88 | -5.98 | 0.9 | |||||
Total Debt / (EBITDA - Capex) | 0.05 | -1.2 | -1.04 | -9.21 | 4.63 | |||||
Net Debt / (EBITDA - Capex) | -0.23 | 1.53 | 0.66 | 12.65 | 1.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 126.07 | -65.94 | -59.49 | 11.39 | 38.93 | |||||
Gross Profit, 1 Yr. Growth % | 289.37 | -91.41 | -93.25 | 312.5 | 87.27 | |||||
EBITDA, 1 Yr. Growth % | 327.06 | -94.19 | -132.49 | -145.12 | 291.24 | |||||
EBITA, 1 Yr. Growth % | 360.42 | -97.4 | -287.12 | -65.04 | -109.98 | |||||
EBIT, 1 Yr. Growth % | 361.03 | -97.43 | -290.94 | -64.58 | -107.89 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 337.38 | -96.4 | -414.48 | -97.58 | -673.72 | |||||
Net Income, 1 Yr. Growth % | 336.49 | -96.45 | -418.65 | -97.92 | -803.18 | |||||
Normalized Net Income, 1 Yr. Growth % | 363.06 | -96.56 | -235.77 | -71.39 | -159.32 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 339.97 | -97.06 | -510.16 | -92.99 | -261.72 | |||||
Accounts Receivable, 1 Yr. Growth % | -29.8 | -57.3 | -27.73 | 104.26 | 24.09 | |||||
Inventory, 1 Yr. Growth % | 114.12 | -49.67 | -47.91 | 25 | -8.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 29.82 | 13.83 | -14.03 | -7.39 | -8.21 | |||||
Total Assets, 1 Yr. Growth % | 12.36 | -17.03 | -13 | -1.47 | -9.78 | |||||
Tangible Book Value, 1 Yr. Growth % | 19.5 | -6.65 | -12.59 | -1.62 | -21.24 | |||||
Common Equity, 1 Yr. Growth % | 16.24 | -5.76 | -12.8 | -1.44 | -18.15 | |||||
Cash From Operations, 1 Yr. Growth % | 126.5 | -97.72 | -30.91 | -82.9 | 1.35K | |||||
Capital Expenditures, 1 Yr. Growth % | 65.49 | -28.82 | -61.61 | -60.86 | -2.97 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 115.64 | -119.17 | -72.57 | -139.24 | -37.67 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 113.7 | -119.1 | -73.36 | -143.12 | -27.42 | |||||
Dividend Per Share, 1 Yr. Growth % | 316.15 | -97.56 | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 84.6 | -12.25 | -62.86 | -32.83 | 24.4 | |||||
Gross Profit, 2 Yr. CAGR % | 254.39 | -42.18 | -92.39 | -47.25 | 177.94 | |||||
EBITDA, 2 Yr. CAGR % | 295.47 | -50.17 | -85.93 | -61.71 | 25.19 | |||||
EBITA, 2 Yr. CAGR % | 362.38 | -65.39 | -76.76 | -19.12 | -80.82 | |||||
EBIT, 2 Yr. CAGR % | 365.36 | -65.61 | -76.68 | -17.76 | -82.84 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 361.38 | -60.32 | -66.36 | -72.42 | -62.75 | |||||
Net Income, 2 Yr. CAGR % | 361.34 | -60.62 | -66.36 | -74.26 | -61.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | 388.6 | -60.11 | -77.53 | -37.68 | -57.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 357.92 | -64.04 | -65.28 | -46.37 | -66.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.93 | -45.25 | -44.45 | 21.5 | 59.21 | |||||
Inventory, 2 Yr. CAGR % | 34.43 | 3.81 | -48.8 | -19.31 | 7.05 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 29.66 | 21.56 | -1.08 | -10.77 | -7.8 | |||||
Total Assets, 2 Yr. CAGR % | 31.14 | -3.44 | -15.04 | -7.41 | -5.72 | |||||
Tangible Book Value, 2 Yr. CAGR % | 114.19 | 5.62 | -9.67 | -7.27 | -11.97 | |||||
Common Equity, 2 Yr. CAGR % | 68.09 | 4.67 | -9.35 | -7.29 | -10.18 | |||||
Cash From Operations, 2 Yr. CAGR % | 285.68 | -77.25 | -87.56 | -65.63 | 57.63 | |||||
Capital Expenditures, 2 Yr. CAGR % | 53.26 | 8.54 | -47.72 | -61.24 | -38.37 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 225.16 | -35.7 | -77.28 | -67.19 | -52.19 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 244.57 | -36.1 | -77.66 | -66.11 | -45.8 | |||||
Dividend Per Share, 2 Yr. CAGR % | 343.76 | -68.15 | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 57.09 | 5.09 | -32.18 | -46.44 | -14.41 | |||||
Gross Profit, 3 Yr. CAGR % | 136.21 | 2.55 | -71.75 | -71.2 | -19.53 | |||||
EBITDA, 3 Yr. CAGR % | 150.56 | -3.12 | -56.12 | -79.25 | -20.15 | |||||
EBITA, 3 Yr. CAGR % | 169.72 | -17.75 | -37.12 | -73.37 | -59.02 | |||||
EBIT, 3 Yr. CAGR % | 170.24 | -17.79 | -36.94 | -73.19 | -61.68 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 162.37 | -8.5 | -20.89 | -86.01 | -24.16 | |||||
Net Income, 3 Yr. CAGR % | 162.56 | -8.9 | -20.94 | -86.7 | -22.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | 169.72 | -6.39 | -38.4 | -75.65 | -37.27 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 157.25 | -14.9 | -19.05 | -79.63 | -22.52 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.32 | -25.67 | -39.94 | -14.26 | 22.36 | |||||
Inventory, 3 Yr. CAGR % | 31.42 | -3.11 | -17.51 | -31.06 | -15.8 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 25.59 | 24.15 | 8.31 | -3.22 | -9.92 | |||||
Total Assets, 3 Yr. CAGR % | 22.69 | 12.58 | -6.74 | -10.74 | -8.21 | |||||
Tangible Book Value, 3 Yr. CAGR % | 83.55 | 62.4 | -0.83 | -7.06 | -12.18 | |||||
Common Equity, 3 Yr. CAGR % | 44.35 | 38.6 | -1.51 | -6.78 | -11.06 | |||||
Cash From Operations, 3 Yr. CAGR % | 184.13 | -30.22 | -67.28 | -86.17 | 19.73 | |||||
Capital Expenditures, 3 Yr. CAGR % | 42.73 | 18.69 | -23.24 | -52.53 | -47.37 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 116.97 | 26.56 | -51.9 | -72.74 | -60.27 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 120.65 | 31.39 | -52.57 | -72.18 | -57.23 | |||||
Dividend Per Share, 3 Yr. CAGR % | 159.11 | -21.7 | - | - | -26.32 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 41.46 | 10.33 | -11.77 | -12.13 | -13.56 | |||||
Gross Profit, 5 Yr. CAGR % | 79.51 | 9.51 | -40.22 | -21.39 | -29.49 | |||||
EBITDA, 5 Yr. CAGR % | 83.33 | 6.7 | -20.82 | -32.55 | -33.26 | |||||
EBITA, 5 Yr. CAGR % | 91.42 | -4.39 | 1.16 | -16.6 | -60.89 | |||||
EBIT, 5 Yr. CAGR % | 91.48 | -4.63 | 1.43 | -16.04 | -62.53 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 84.86 | -3.15 | 15.37 | -43.37 | -41.47 | |||||
Net Income, 5 Yr. CAGR % | 84.74 | -3.57 | 15.43 | -45.05 | -40.88 | |||||
Normalized Net Income, 5 Yr. CAGR % | 87.09 | -1.98 | -0.19 | -19.18 | -46.83 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 81.99 | -8.33 | 15.46 | -29.25 | -43.01 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.64 | -10.09 | -23.02 | -9.52 | -11.3 | |||||
Inventory, 5 Yr. CAGR % | 34.06 | 12.89 | -9.86 | -9.95 | -8.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 29.23 | 25.93 | 14.16 | 8.79 | 1.55 | |||||
Total Assets, 5 Yr. CAGR % | 29.86 | 22.11 | 5.92 | 4.11 | -6.33 | |||||
Tangible Book Value, 5 Yr. CAGR % | 28.53 | 23.61 | 38.23 | 29.79 | -5.45 | |||||
Common Equity, 5 Yr. CAGR % | 31.57 | 26.87 | 19.84 | 18.01 | -5.08 | |||||
Cash From Operations, 5 Yr. CAGR % | 78.35 | -14.04 | -18.72 | -47.64 | -38.63 | |||||
Capital Expenditures, 5 Yr. CAGR % | 41.98 | 14.66 | -4.49 | -24.14 | -29.7 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 108.32 | 31.3 | -12.02 | -26.53 | -52.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 107.17 | 31.66 | -11.72 | -23.88 | -49.97 | |||||
Dividend Per Share, 5 Yr. CAGR % | 82.68 | -13.09 | - | - | -47.32 |
- Stock Market
- Stocks
- TOPGLOV Stock
- Financials Top Glove Corporation Bhd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















